Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Spotlight Review
  • Published:

Review

Cell death beyond apoptosis

Leukemia volume 14, pages 1502–1508 (2000)Cite this article

Abstract

Though the term apoptosis was originated in pathology and developmental biology as an alternative to necrosis, the tissue necrosis with inflammation is irrelevant to cell culture conditions where apoptosis is mostly studied. Furthermore, no one single morphological feature is either necessary or sufficient to define apoptosis. The emerging biochemical definition, a cell death with caspase activation, allows the distinction of alternative forms of cell death. Thus, inhibition of caspases delays but does not prevent cell death. Slow cell death without caspase activation may nevertheless be associated with DNA fragmentation. Oncogenic Ras, Raf, and mitogen-activated kinases inhibit apoptosis by affecting the cytochrome C/caspase-9 pathway but may arrest growth and cause slow cell death with delayed DNA fragmentation. Such ‘slow’ cell death without caspase activation is often caused by chemotherapeutic drugs. Whether a cell will undergo apoptosis or slow death depends not only on a chemotherapeutic agent but also on the readiness of cellular caspases. Therefore, one can distinguish apoptosis-prone (eg leukemia) vs apoptosis-resistant cells. Cell susceptibilities to spontaneous, starvation-induced and drug-induced apoptosis are correlated and characterize an apoptosis-prone phenotype. Finally, distinction of slow cell death allows rephrasing of a question regarding the goal of cancer therapy: apoptosis vs slow cell death, or cancer cell-selectivity regardless of the mode of cell death.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Kerr JFR, Wyllie AH, Currie AR . Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics Br J Cancer 1972 26: 239–257

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Vaux DL . Caspases and apoptosis – biology and terminology Cell Death Differ 1999 6: 493–494

    Article  CAS  PubMed  Google Scholar 

  3. Saunders JJW . Death in embryonic systems Science 1966 154: 604–612

    Article  PubMed  Google Scholar 

  4. Kitanaka C . Kuchino Y. Caspase-independent programmed cell death with necrotic morphology Cell Death Differ 1999 6: 508–515

    Article  CAS  PubMed  Google Scholar 

  5. Martin SJ . Protein or RNA synthesis inhibition induces apoptosis of mature human CD4+ T cell blasts Immunol Lett 1993 35: 125–134

    Article  CAS  PubMed  Google Scholar 

  6. Solary E, Bertrand R, Kohn KW, Pommier Y . Differential induction of apoptosis in undifferentiated and differentiated HL-60 cells by DNA topoisomerase I and II inhibitors Blood 1993 81: 1359–1368

    CAS  PubMed  Google Scholar 

  7. Borner MM, Myers CE, Sartor O, Sei Y, Toko T, Trepel JB, Schneider E . Drug-induced apoptosis is not necessarily dependent on macromolecular synthesis or proliferation in the p53-negative human prostate cancer cell line PC-3 Cancer Res 1995 55: 2122–2128

    CAS  PubMed  Google Scholar 

  8. Weil M, Jacobson MD, Coles HSR, Davies TJ, Gardner RL, Raff KD, Raff MC . Constitutive expression of the machinery for programmed cell death J Cell Biol 1996 133: 1053–1059

    Article  CAS  PubMed  Google Scholar 

  9. Wesselborg S, Engels IH, Rossmann E, Los M, Schulze-Osthoff K . Anticancer drugs induce caspase-8/FLICE activation and apoptosis in the absence of CD95 receptor/ligand interaction Blood 1999 93: 3053–3063

    CAS  PubMed  Google Scholar 

  10. Li YZ, Li CJ, Pinto AV, Pardee AB . Release of mitochondrial cytochrome C in both apoptosis and necrosis induced by beta-lapachone in human carcinoma cells Mol Med 1999 5: 232–239

    Article  PubMed  PubMed Central  Google Scholar 

  11. Nagata S . Apoptosis by death factor Cell 1997 88: 355–365

    Article  CAS  PubMed  Google Scholar 

  12. Ashkenasi A, Dixit VM . Death receptors: signaling and modulation Science 1998 281: 1305–1308

    Article  Google Scholar 

  13. Thornberry NA, Lazebnik Y . Caspases: enemies within Science 1998 281: 1312–1316

    Article  CAS  PubMed  Google Scholar 

  14. Green DR . Apoptotic pathways: the roads to ruin Cell 1998 94: 695–698

    Article  CAS  PubMed  Google Scholar 

  15. Kumar S . Mechanisms mediating caspase activation in cell death Cell Death Differ 1999 6: 1060–1066

    Article  CAS  PubMed  Google Scholar 

  16. Green DR, Reed JC . Mitochondria and apoptosis Science 1998 281: 1309–1312

    Article  CAS  PubMed  Google Scholar 

  17. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC . Cleavage of poly(ADP-ribose)polymerase by a proteinase with properties like ICE Nature 1994 371: 346–347

    Article  CAS  PubMed  Google Scholar 

  18. Liu X, Zou H, Slaughter C, Wang X . DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis Cell 1997 89: 175–184

    Article  CAS  PubMed  Google Scholar 

  19. Janicke RU, Sprengart ML, Wati MR, Porter AG . Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis J Biol Chem 1998 273: 9357–9360

    Article  CAS  PubMed  Google Scholar 

  20. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S . A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD Nature 1998 391: 43–50

    Article  CAS  PubMed  Google Scholar 

  21. McIlroy D, Sakahira H, Talanian RV, Nagata S . Involvement of caspase 3-activated DNase in internucleosomal DNA cleavage induced by diverse apoptotic stimuli Oncogene 1999 18: 4401–4408

    Article  CAS  PubMed  Google Scholar 

  22. Mills JC, Stone NL, Pittman RN . Extranuclear apoptosis: the role of the cytoplasm in the execution phase J Cell Biol 1999 146: 703–707

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Martin SJ, Finucance DM, Amarante-Mendes GP, O'Brien GA, Green DR . Phosphatidylserine externalization during CD95-induced apoptosis of cells and cytoplasts requires ICE/CED-3 protease activity J Biol Chem 1996 271: 28753–28756

    Article  CAS  PubMed  Google Scholar 

  24. Samali A, Zhivotovsky B, Jones D, Nagata S, Orrenius S . Apoptosis: cell death defined by caspase activation Cell Death Differ 1999 6: 495–496

    Article  CAS  PubMed  Google Scholar 

  25. Oberhammer F, Wilson JW, Dive C, Morris ID, Hickman JA, Wakeling AE, Walker PR, Sikorska M . Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50kb fragments prior to or in the absence of internucleosomal fragmentation EMBO J 1993 12: 3679–3684

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Ormerod MG, Oneill CF, Robertson D, Harrap KR . Cisplatin induces apoposis in a human ovarian-carcinoma cell-line without concomitant internucleosomal degradation of DNA Exp Cell Res 1994 211: 231–237

    Article  CAS  PubMed  Google Scholar 

  27. Rasola A, Farahi Far D, Hofman P, Rossi B . Lack of internucleosomal DNA fragmentation is related to Cl(−) efflux impairment in hematopoietic cell apoptosis FASEB J 1999 13: 1711–1723

    Article  CAS  PubMed  Google Scholar 

  28. Dong Z, Saikumar P, Weinberg JM, Venkatachalam MA . Internucleosomal DNA cleavage triggered by plasma membrane damage during necrotic cell death. Involvement of serine but not cystein proteases Am J Pathol 1997 151: 1205–1213

    CAS  PubMed  PubMed Central  Google Scholar 

  29. Khodarev NN, Sokolova IA, Vaughan AT . Mechanisms of induction of apoptotic DNA fragmentation Int J Radiat Biol 1998 73: 455–467

    Article  CAS  PubMed  Google Scholar 

  30. Chautan M, Chazal G, Cecconi F, Gruss P, Golstein P . Interdigital cell death can occur through a necrotic and caspase-independent pathway Curr Biol 1999 9: 967–970

    Article  CAS  PubMed  Google Scholar 

  31. Shimizu T, Pommier Y . Camptothecin-induced apoptosis in p53-null human leukemia HL60 cells and their isolated nuclei: effects of the protease inhibitors Z-VAD-fmk and dichloroisocoumarin suggest an involvement of both caspases and serine proteases Leukemia 1997 11: 1238–1244

    Article  CAS  PubMed  Google Scholar 

  32. Zeuner A, Eramo A, Peschle C, De Maria R . Caspase activation without death Cell Death Differ 1999 6: 1075–1080

    Article  CAS  PubMed  Google Scholar 

  33. Hirsch T, Marchetti P, Susin SA, Dallaporta B, Zamzami N, Marzo I, Geuskens M, Kroemer G . The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial premeability transition determine the mode of cell death Oncogene 1997 15: 1573–1581

    Article  CAS  PubMed  Google Scholar 

  34. Amarante-Mendes GP, Finucane DM, Martin SJ, Cotter TG, Salvesen GS, Green DR . Anti-apoptotic oncogenes prevent caspase-dependent and independent commitment for cell death Cell Death Differ 1998 5: 298–306

    Article  CAS  PubMed  Google Scholar 

  35. Borner C, Monney L . Apoptosis without caspases: an inefficient molecular guillotine Cell Death Differ 1999 6: 497–507

    Article  CAS  PubMed  Google Scholar 

  36. Kolenko V, Uzzo RG, Bukowski R, Bander NH, Novick AC, Hsi ED, Finke JH . Dead or dying: necrosis vs apoptosis in caspase-deficient human renal cell carcinoma Cancer Res 1999 59: 2838–2842

    CAS  PubMed  Google Scholar 

  37. Houghton JA . Apoptosis and drug response Curr Opin Oncol 1999 11: 475–481

    Article  CAS  PubMed  Google Scholar 

  38. Reed JC . Double identity for proteins of the Bcl-2 family Nature 1997 387: 773–776

    Article  CAS  PubMed  Google Scholar 

  39. Shinoura N, Yoshida Y, Nishimura M, Muramatsu Y, Asai A, Kirino T, Hamada H . Expression level of Bcl-2 determines anti- or proapoptotic function Cancer Res 1999 59: 4119–4128

    CAS  PubMed  Google Scholar 

  40. Cheng EH, Kirsch DG, Clem RJ, Ravi R, Kastan MB, Bedi A, Ueno K, Hardwick JM . Conversion of Bcl-2 to a Bax-like death effector by caspases Science 1997 278: 1966–1968

    Article  CAS  PubMed  Google Scholar 

  41. Fadeel B, Hassan Z, Hellstrom-Lindberg M, Henter J-I, Orrenius S, Zhivotovsky B . Cleavage of bcl-2 is an early event in chemotherapy-induced apoptosis of human myeloid leukemia cells Leukemia 1999 13: 719–728

    Article  CAS  PubMed  Google Scholar 

  42. Blagosklonny MV, Chuman Y, Bergan RC, Fojo T . Mitogen-activated protein kinase pathway is dispensible for microtubule-active drug-induced Raf-1/Bcl-2 phosphorylation and apoptosis in leukemia cells Leukemia 1999 13: 1028–1036

    Article  CAS  PubMed  Google Scholar 

  43. Lassus P, Ferlin M, Piette J, Hibner U . Anti-apoptotic activity of low levels of wild-type p53 EMBO J 1996 15: 4566–4573

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Evan G, Littlewood T . A matter of life and cell death Science 1998 281: 1317–1322

    Article  CAS  PubMed  Google Scholar 

  45. Blagosklonny MV . A node between proliferation, apoptosis, and growth arrest Bioessays 1999 21: 704–709

    Article  CAS  PubMed  Google Scholar 

  46. Kauffman-Zeh A, Rodriguez-Viciana P, Ulrich E, Gilbert C, Coffer P, Downward J, Evan G . Suppression of c-myc-induced apoptosis by Ras signalling through PI(3)K and PKB Nature 1997 385: 544–548

    Article  Google Scholar 

  47. Erhardt P, Schremser EJ, Cooper GM . B-Raf inhibits programmed cell death downstream of cytochrome c release from mitochondria by activating the MEK/Erk pathway Mol Cell Biol 1999 19: 5308–5315

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Bonni A, Brunet A, West AE, Datta SR, Takasu MA, Greenberg ME . Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms Science 1999 286: 1358–1362

    Article  CAS  PubMed  Google Scholar 

  49. Dubrez L, Eymin B, Sordet O, Droin N, Turhan AG, Solary E . BCR-ABL delays apoptosis upstream of procaspase-3 activation Blood 1998 91: 2415–2422

    CAS  PubMed  Google Scholar 

  50. Amarante-Mendes GP, Naekyung Kim C, Liu L, Huang Y, Perkins CL, Green DR, Bhalla K . Bcr-Abl exerts its antiapoptotic effect against diverse apoptotic stimuli through blockage of mitochondrial release of cytochrome C and activation of caspase-3 Blood 1998 91: 1700–1705

    CAS  PubMed  Google Scholar 

  51. Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, Frisch S, Reed JC . Regulation of cell death protease caspase-9 by phosphorylation Science 1998 282: 1318–1321

    Article  CAS  PubMed  Google Scholar 

  52. Zhu J, Woods D, McMahon M, Bishop JM . Senescence of human fibroblasts induced by oncogenic Raf Genes Dev 1998 12: 2997–3007

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Arber N . Janus faces of ras: anti or pro-apoptotic? Apoptosis 1999 4: 383–388

    Article  CAS  PubMed  Google Scholar 

  54. Rak J, Mitsuhashi Y, Erdos V, Huang SN, Filmus J, Kerbel RS . Massive programmed cell death in intestinal epithelial cells induced by three-dimensional growth conditions: suppression by mutant c-H-ras oncogene expression J Cell Biol 1995 131: 1587–1598

    Article  CAS  PubMed  Google Scholar 

  55. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW . Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a Cell 1997 88: 593–602

    Article  CAS  PubMed  Google Scholar 

  56. Chi S, Kitanaka C, Noguchi K, Mochizuki T, Nagashima Y, Shirouzu M, Fujita H, Yoshida M, Chen W, Asai A, Himeno M, Yokoyama S, Kuchino Y . Oncogenic Ras triggers cell suicide through the activation of a caspase-independent cell death program in human cancer cells Oncogene 1999 18: 2281–2290

    Article  CAS  PubMed  Google Scholar 

  57. Chen CY, Liou J, Forman LW, Faller DV . Differential regulation of discrete apoptotic pathways by Ras J Biol Chem 1998 273: 16700–16709

    Article  CAS  PubMed  Google Scholar 

  58. Miranda EI, Santana C, Rojas E, Hernandez S, Ostrosky-Wegman P, Garcia-Carranca A . Induced mitotic death of HeLa cells by abnormal expression of c-H-ras Mutat Res 1996 349: 173–182

    Article  PubMed  Google Scholar 

  59. Blagosklonny MV, Wu GS, Omura S, El-Deiry WS . Proteasome-dependent regulation of p21WAF1/CIP1 expression Biochem Biophys Res Comm 1996 227: 564–569

    Article  CAS  PubMed  Google Scholar 

  60. Canman CE, Gilmer TM, Coutts SB, Kastan MB . Growth factor modulation of p53-mediated growth arrest versus apoptosis Genes Dev 1995 9: 600–611

    Article  CAS  PubMed  Google Scholar 

  61. McCubrey JA, Steelman LS, Hoyle PE, Blalock WL, Weinstein-Oppenheimer C, Franklin RA, Cherwinski H, Bosch E, McMahon M . Differential abilities of activated Raf oncoproteins to abrogate cytokine dependency, prevent apoptosis and induce autocrine growth factor synthesis in human hematopoietic cells Leukemia 1998 12: 1903–1929

    Article  CAS  PubMed  Google Scholar 

  62. El-Ashry D, Miller DL, Kharbanda S, Lippman ME, Kern FG . Constitutive Raf-1 kinase activity in breast cancer cells induces both estrogen-independent growth and apoptosis Oncogene 1997 15: 423–435

    Article  CAS  PubMed  Google Scholar 

  63. Hall-Jackson CA, Jones T, Eccles NG, Dawson TP, Bond JA, Gescher A, Wynford-Thomas D . Induction of cell death by stimulation of protein kinase C in human epithelial cells expressing a mutant ras oncogene: a potential therapeutic target Br J Cancer 1998 78: 641–651

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Solary E, Bertrand R, Pommier Y . Apoptosis of human leukemic HL-60 cells induced to differentiate by phorbol ester treatment Leukemia 1994 8: 792–797

    CAS  PubMed  Google Scholar 

  65. Blagosklonny MV . The mitogen-activated protein kinase pathway mediates growth arrest or E1A-dependent apoptosis in SKBr3 human breast cancer cells Int J Cancer 1998 78: 511–517

    Article  CAS  PubMed  Google Scholar 

  66. McCubrey JA, Steelman LS, Sandlin G, Riddle RS, Ways DK . Effects of phorbol esters on an interleukin-3-dependent cell line Blood 1990 76: 63–72

    CAS  PubMed  Google Scholar 

  67. Chang B-D, Xuan Y, Broude EV, Zhu H, Schott B, Fang J, Roninson IB . Role of p53 and p21 waf1/cip1 in senescence-like terminal proliferation arrest induced in human cells by chemotherapeutic drugs Oncogene 1999 18: 4808–4818

    Article  CAS  PubMed  Google Scholar 

  68. Chang B-D, Broude EV, Dokmanovic M, Zhu H, Ruth A, Xuan Y, Kandel ES, Lausch E, Christov K, Roninson IB . A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer drugs Cancer Res 1999 59: 3761–3767

    CAS  PubMed  Google Scholar 

  69. Kravtsov VD, Greer JP, Whitlock JA, Koury MJ . Use of the microculture kinetic assay of apoptosis to determine chemosensitivities of leukemias Blood 1998 92: 968–980

    CAS  PubMed  Google Scholar 

  70. Classen CF, Fulda S, Friesen C, Debatin KM . Decreased sensitivity of drug-resistant cells towards T cell cytotoxicity Leukemia 1999 13: 410–418

    Article  CAS  PubMed  Google Scholar 

  71. Friesen C, Fulda S, Debatin KM . Deficient activation of the CD95 (APO-1/Fas) system in drug-resistant cells Leukemia 1997 11: 1833–1841

    Article  CAS  PubMed  Google Scholar 

  72. Antoku K, Liu Z, Johnson DE . Inhibition of caspase proteases by CrmA enhances the resistance of human leukemic cells to multiple chemotherapeutic agents Leukemia 1997 11: 1665–1672

    Article  CAS  PubMed  Google Scholar 

  73. Bullock G, Ray S, Reed JC, Krajewski S, Ibrado AM, Huang Y, Bhalla K . Intracellular metabolism of Ara-C and resulting DNA fragmentation and apoptosis of human AML HL-60 cells possessing disparate levels of Bcl-2 protein Leukemia 1996 10: 1731–1740

    CAS  PubMed  Google Scholar 

  74. Turnbull KJ, Brown BL, Dobson PR . Caspase-3-like activity is necessary but not sufficient for daunorubicin-induced apoptosis in Jurkat human lymphoblastic leukemia cells Leukemia 1999 13: 1056–1061

    Article  CAS  PubMed  Google Scholar 

  75. Kawabata Y, Hirokawa M, Kitabayashi A, Horiuchi T, Kuroki J, Miura AB . Defective apoptotic signal transduction pathway downstream of caspase-3 in human B-lymphoma cells: a novel mechanism of nuclear resistance Blood 1999 94: 3523–3530

    CAS  PubMed  Google Scholar 

  76. Roberts JR, Allison DC, Donehower RC, Rowinsky EK . Development of polyploidization in taxol resistant human leukemia cells in vitro Cancer Res 1990 50: 710–716

    CAS  PubMed  Google Scholar 

  77. Martins LM, Mesner PW, Kottke Tj, Basi GS, Sinha S, Tung JS, Svingen PA, Madden BJ, Takahashi A, McCormick DJ, Earnshaw WC, Kaufmann SH . Comparison of caspase activation and subcellular localization in HL-60 and K562 cells undergoing etoposide-induced apoptosis Blood 1997 90: 4283–4296

    CAS  PubMed  Google Scholar 

  78. An WG, Hwang SG, Trepel JB, Blagosklonny MV . Protease inhibitor-induced apoptosis: accumulation wt p53, p21WAF1/CIP1, and induction of apoptosis are independent markers of proteasome inhibition Leukemia 2000 14: 1276–1283

    Article  CAS  PubMed  Google Scholar 

  79. Smith BD, Bambach BJ, Vala MS, Barber JP, Enger C, Brodsky RA, Burke PJ, Gore SD, Jones RJ . Inhibited apoptosis and drug resistance in acute myeloid leukaemia Br J Haematol 1998 102: 1042–1049

    Article  CAS  PubMed  Google Scholar 

  80. Efferth T, Fabry U, Osieka R . Apoptosis and resistance to daunorubicin in human leukemic cells Leukemia 1997 11: 1180–1186

    Article  CAS  PubMed  Google Scholar 

  81. Blagosklonny MV, Somasundaram K, Wu GS, El-Deiry WS . Wild-type p53 is not sufficient for serum starvation-induced apoptosis in cancer cells but accelerates apoptosis in sensitive cells Int J Oncol 1997 11: 1165–1170

    CAS  PubMed  Google Scholar 

  82. Wuchter C, Karawajew L, Ruppert V, Buchner T, Schoch C, Haferlach T, Ratei R, Dorken B, Ludwig WD . Clinical significance of CD95, Bcl-2 and Bax expression and CD95 function in adult de novo acute myeloid leukemia in context of P-glycoprotein function, maturation stage, and cytogenetics Leukemia 1999 13: 1943–1953

    Article  CAS  PubMed  Google Scholar 

  83. Kakihara T, Fukuda T, Kamishima T, Naito M, Tanaka A, Uchiyama M, Kishi K . Resistance to apoptosis induced by serum depletion and all-trans retinoic acid in drug-resistant leukemic cell lines Leuk Lymphoma 1997 26: 369–376

    Article  CAS  PubMed  Google Scholar 

  84. Nieves-Neira W, Pommier Y . Apoptotic response to camptothecin and 7-hydroxystaurosporine (UCN-01) in the 8 human breast cancer cell lines of the NCI Anticancer Drug Screen: multifactorial relationships with topoisomerase I, protein kinase C, Bcl-2, p53, MDM-2 and caspase pathways Int J Cancer 1999 82: 396–404

    Article  CAS  PubMed  Google Scholar 

  85. Los M, Herr I, Friesen C, Fulda S, Schulze-Osthoff K, Debatin KM . Cross-resistance of CD95- and drug-induced apoptosis as a consequence of deficient activation of caspases (ICE/Ced-3 proteases) Blood 1997 90: 3118–3129

    CAS  PubMed  Google Scholar 

  86. Meinhardt G, Roth J, Totok G, Auner H, Emmerich B, Hass R . Signaling defect in the activation of caspase-3 and PKCdelta in human TUR leukemia cells is associated with resistance to apoptosis Exp Cell Res 1999 247: 534–542

    Article  CAS  PubMed  Google Scholar 

  87. Sane AT, Bertrand R . Distinct steps in DNA fragmentation pathway during camptothecin-induced apoptosis involved caspase-, benzyloxycarbonyl- and N-tosyl-L-phenylalanylchloromethyl ketone-sensitive activities Cancer Res 1998 58: 3066–3072

    CAS  PubMed  Google Scholar 

  88. Lorenzo HK, Susin SA, Penninger J, Kroemer G . Apoptosis inducing factor (AIF): a phylogenetically old, caspase-independent effector of cell death Cell Death Differ 1999 6: 516–524

    Article  CAS  PubMed  Google Scholar 

  89. Kataoka A, Kubota M, Wakazono Y, Okuda A, Bessho R, Lin YW, Usami I, Akiyama Y, Furusho K . Association of high-molecular-weight DNA fragmentation with apoptotic or non-apoptotic cell-death induced by calcium ionophore FEBS Lett 1995 364: 264–267

    Article  CAS  PubMed  Google Scholar 

  90. Simm A, Bertsch G, Frank H, Zimmermann U, Hoppe J . Cell death of AKR-2B fibroblasts after serum removal: a process between apoptosis and necrosis J Cell Sci 1997 110: 819–828

    CAS  PubMed  Google Scholar 

  91. Gorczyca W, Bigman K, Mittelman A, Ahmed T, Gong JP, Melamed MR, Darzynkiewicz Z . Induction of DNA strand breaks associated with apoptosis during treatment of leukemias Leukemia 1993 7: 659–670

    CAS  PubMed  Google Scholar 

  92. Stoetzer OJ, Pogrebniak A, Scholz M, Pelka-Fleischer R, Gullis E, Darsow M, Nussler V, Wilmanns W . Drug-induced apoptosis in chronic lymphocytic leukemia Leukemia 1999 13: 1873–1880

    Article  CAS  PubMed  Google Scholar 

  93. Ibrado AM, Liu L, Bhalla K . Bcl-xL overexpression inhibits progression of molecular events leading to paclitaxel-induced apoptosis of human AML HL-60 cells Cancer Res 1997 57: 1109–1115

    CAS  PubMed  Google Scholar 

  94. Datta R, Banach D, Kojima H, Talanian RV, Alnemri ES, Wong WW, Kufe DW . Activation of the CPP32 protease in apoptosis induced by 1-b-D arabinofuranosylcytosine and other DNA-damaging agents Blood 1996 88: 1936–1943

    CAS  PubMed  Google Scholar 

  95. Fisher DE . Apoptosis in cancer therapy: crossing the threshold Cell 1994 78: 539–542

    Article  CAS  PubMed  Google Scholar 

  96. Shao RG, Shimizu T, Pommier Y . 7-Hydroxystaurosporine (UCN-01) induces apoptosis in human colon carcinoma and leukemia cells independently of p53 Exp Cell Res 1997 234: 388–397

    Article  CAS  PubMed  Google Scholar 

  97. Senderowicz AM, Headlee D, Stinson SF, Lush RM, Kalil N, Villalba L, Hill K, Steinberg SM, Figg WD, Tompkins A, Arbuck SG, Sausville EA . Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms J Clin Oncol 1998 16: 2986–2999

    Article  CAS  PubMed  Google Scholar 

  98. Parker BW, Kaur G, Nieves-Neira W, Taimi M, Kohlhagen G, Shimizu T, Losiewicz MD, Pommier Y, Sausville EA, Senderowicz AM . Early induction of apoptosis in hematopoietic cell lines after exposure to flavopiridol Blood 1998 91: 458–465

    CAS  PubMed  Google Scholar 

  99. Akiyama T, Yoshida T, Tsujita T, Shimizu M, Mizukami T, Okabe M, Akinaga S . G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells Cancer Res 1997 57: 1495–1501

    CAS  PubMed  Google Scholar 

  100. Sugiyama K, Akiyama T, Shimizu M, Tamaoki T, Courage C, Gescher A, Akinaga S . Decrease in susceptibility toward induction of apoptosis and alteration in G1 checkpoint function as determinants of resistance of human lung cancer cells against the antisignaling drug UCN-01 (7-hydroxystaurosporine) Cancer Res 1999 59: 4406–4412

    CAS  PubMed  Google Scholar 

  101. Kruger EA, Blagosklonny MV, Dixon SC, Figg WD . UCN-01, a protein kinase C inhibitor, inhibits endothelial proliferation and angiogenic hypoxic response Invas Metast 2000 18: 209–218

    Article  Google Scholar 

  102. Patel V, Senderowicz AM, Pinto DJ, Igishi T, Raffeld M, Quintanilla-Martinez L, Ensley JF, Sausville EA, Gutkind JS . Flavopiridol, a novel cyclin-dependent kinase inhibitor, suppresses the growth of head and neck squamous cell carcinomas by inducing apoptosis J Clin Invest 1998 102: 1674–1681

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  103. Drexler HC . Activation of the cell death program by inhibition of proteasome function Proc Natl Acad Sci USA 1997 94: 855–860

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  104. Orlowski RZ . The role of the ubiquitin-proteasome pathway in apoptosis Cell Death Differ 1999 6: 303–313

    Article  CAS  PubMed  Google Scholar 

  105. Chandra J, Niemer I, Gilbreath J, Kliche KO, Andreeff M, Freireich EJ, Keating M, McConkey DJ . Proteasome inhibitors induce apoptosis in glucocorticoid-resistant chronic lymphocytic leukemic lymphocytes Blood 1998 92: 4220–4229

    CAS  PubMed  Google Scholar 

  106. Adams J, Palombella VJ, Sausville EA, Johnson J, Destree A, Lazarus DD, Maas J, Pien CS, Prakash S, Elliott PJ . Proteasome inhibitors: a novel class of potent and effective antitumor agents Cancer Res 1999 59: 2615–2622

    CAS  PubMed  Google Scholar 

  107. An B, Goldfarb RH, Siman R, Dou QP . Novel dipeptidyl proteasome inhibitors overcome Bcl-2 protective function and selectively accumulate the cyclin-dependent kinase inhibitor p27 and induce apoptosis in transformed, but not normal, human fibroblasts Cell Death Differ 1998 5: 1062–1075

    Article  CAS  PubMed  Google Scholar 

  108. Squier MK, Sehnert AJ, Cohen JJ . Apoptosis in leukocytes J Leuk Biol 1995 57: 2–10

    Article  CAS  Google Scholar 

  109. Metcalfe A, Streuli C . Epithelial apoptosis Bioessays 1997 19: 711–720

    Article  CAS  PubMed  Google Scholar 

  110. Reed JC . Dysregulation of apoptosis in cancer J Clin Oncol 1999 17: 2941–2954

    Article  CAS  PubMed  Google Scholar 

  111. Schmitt CA, Lowe SW . Apoptosis and therapy J Pathol 1999 187: 127–137

    Article  CAS  PubMed  Google Scholar 

  112. Kastan MB, Canman CE, Leonard CJ . P53, cell cycle control and apoptosis: implications for cancer Cancer Metast Rev 1995 14: 3–15

    Article  CAS  Google Scholar 

  113. Darzynkiewicz Z . Apoptosis in antitumor strategies – modulation of cell-cycle or differentiation J Cell Biochem 1995 58: 151–159

    Article  CAS  PubMed  Google Scholar 

  114. Fadeel B, Orrenius S, Zhivotovsky B . Apoptosis in human disease: a new skin for the old ceremony Biochem Biophys Res Commun 1999 266: 699–717

    Article  CAS  PubMed  Google Scholar 

  115. Kitada S, Andersen J, Akar S, Zapata JM, Takayama S, Krajewski S, Wang HG, Zhang X, Bullrich F, Croce CM, Rai K, Hines J, Reed JC . Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with in vitro and in vivo chemoresponses Blood 1998 91: 3379–3389

    CAS  PubMed  Google Scholar 

  116. Hannun YA . Apoptosis and the dilemma of cancer chemotherapy Blood 1997 89: 1845–1853

    CAS  PubMed  Google Scholar 

  117. Martin SJ, Green DR . Apoptosis as a goal of cancer therapy Curr Opin Oncol 1994 6: 616–621

    Article  CAS  PubMed  Google Scholar 

  118. Soignet SL, Maslak P, Wang ZG, Jhanwar S, Calleja E, Dardashti LJ, Corso D, DeBlasio A, Gabrilove J, Scheinberg DA, Pandolfi PP, Warrell RPJ . Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide New Engl J Med 1998 339: 1341–1348

    Article  CAS  PubMed  Google Scholar 

  119. Pardee AB, James LJ . Selective killing of transformed baby hamster kidney (BHK) cells Proc Natl Acad Sci USA 1975 72: 4994–4998

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  120. Pardee AB . A restriction point for control of normal animal cell proliferation Proc Natl Acad Sci USA 1974 71: 1286–1290

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  121. Komarov PG, Komarova EA, Kondratov RV, Christov-Tselkov K, Coon JS, Chernov MV, Gudkov AV . A chemical inhibitor of p53 that protects mice from the side-effects of cancer therapy Science 1999 285: 1733–1737

    Article  CAS  PubMed  Google Scholar 

  122. Blagosklonny MV, Robey R, Bates S, Fojo T . Pretreatment with DNA-damaging agents permits selective killing of checkpoint-deficient cells by microtubule-active drugs J Clin Invest 2000 105: 533–539

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  123. Blagosklonny MV . Drug-resistance enables selective killing of resistant leukemia cells: exploiting of drug resistance instead of reversal Leukemia 1999 13: 2031–2035

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medicine Branch, National Cancer Institute, NIH, Bethesda, MD, USA

    MV Blagosklonny

Authors
  1. MV Blagosklonny
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Blagosklonny, M. Cell death beyond apoptosis. Leukemia 14, 1502–1508 (2000). https://doi.org/10.1038/sj.leu.2401864

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2401864

Keywords

This article is cited by

Search

Advanced search

Quick links